GSDMD ligand-1
GSDMD ligand-1 (compound A5) is a synthetic intermediate. GSDMD ligand-1 is used for conjugation with Thalidomide (HY-14658)/CRBN linker fragments to construct PROTACs targeting GSDMD. GSDMD ligand-1 can be used in cancer-related research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Fòrmula: C26H23F2N3O4
- Peso molecular:479.48
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
IC50 & Target
[1]|
GSDMD |
Chemical Information
-
Peso molecular 479.48
-
Fòrmula C26H23F2N3O4
-
SMILES
OC(C1=CC=C(C=C1)C(NC2=CC=C(C=C2)N3CCN(CC3)C(CC4=C(C=C(C=C4)F)F)=O)=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
GSDMD ligand-1 Related Classifications
HY-189672 Related Classifications
Powered by Bioz
Keywords
- GSDMD ligand-1
- GSDMD ligand1
- GSDMD ligand 1
- Drug Intermediate
- Drug Iintermediate
- Synthetic Intermediate
- GSDMD ligand
- GSDMD binder
- GSDMD warhead
- 4-((4-(4-(2-(2
- 4-difluorophenyl)acetyl)piperazin-1-yl)phenyl)carbamoyl)benzoic acid
- PGC analog
- PROTAC building block
- CRBN-recruiting GSDMD PROTAC precursor
- pyroptosis research intermediate
- inflammasome research intermediate
- full-length GSDMD targeting scaffold
- PGC-01 precursor intermediate
- Inhibitor
- inhibitor
- inhibit